Founder · Executive · Researcher
Chris Gibson
Current role not listed
Gibson co-founded Recursion and developed it from a university lab project into a public drug-discovery company. Its platform combines automated cell imaging, large biological datasets, and machine learning to search for new medicines. He served as CEO through January 2026 and left its board that June.
Career & education
Previously
RecursionCo-Founder and ChairmanJan 2026-Jun 2026
Co-Founder and CEONov 2013-Jan 2026
Work and education history is primarily focused on AI-relevant roles and may not be comprehensive.
Citation Trend
Total citations to scholarly work, including research papers, technical reports, books and theses, as recorded by Google Scholar. Each point is a dated snapshot.
citations3,063As of Nov 1, '26
Updates 1
Based on public sources. If accuracy is important, verify details using the links or references.
For corrections, updates, or requests to remove information, contact us.
Reviewed August 12, 2026 · Checked for accuracy and new information.